Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer

Gynecologic Oncology

Volumn 97, Issue 3, 2005, Pages 772-779

  Sonoda, Kenzo ^a   Miyamoto, Shingo ^a   Hirakawa, Toshio ^a   Yagi, Hiroshi ^a   Yotsumoto, Fusanori ^a   Nakashima, Manabu ^b   Watanabe, Takeshi ^c   Nakano, Hitoo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Lymphocyte apoptosis; RCAS1; Uterine cervical cancer

Indexed keywords

FAS LIGAND; RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELL; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; LYMPH NODE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER;

ADULT; AGED; ANTIGENS, NEOPLASM; APOPTOSIS; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 20444489510     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.02.025     Document Type: Article

References (48)

1. S.A. Cannistra, and J.M. Niloff Cancer of the uterine cervix N. Engl. J. Med. 334 1996 1030 1038
2. R.S. Foster Jr. The biologic and clinical significance of lymphatic metastases in breast cancer Surg. Oncol. Clin. N. Am. 5 1996 79 104
3. F.B. Stehman, C.A. Perez, R.J. Kurman, and J.T. Thigpen Uterine cervix W.J. Hoskins C.A. Perez R.C. Young Principles and Practice of Gynecologic Oncology 3rd ed. 2000 Lippincott Williams and Wilkins Philadelphia 841 918
4. W.L. McGuire Prognostic factors for recurrence and survival in human breast cancer Breast Cancer Res. Treat. 10 1987 5 9
5. J.C. Harrison, P.J. Dean, F. El-Zeky, and R. Vander Zwaag From dukes through jass. Pathological prognostic indicators in rectal cancer Hum. Pathol. 25 1994 498 505
6. E. Burghardt, H. Pickel, J. Haas, and M. Lahousen Prognostic factors and operative treatment of stages IB to IIB cervical cancer Am. J. Obstet. Gynecol. 156 1987 988 996
7. H. Noguchi, I. Shiozawa, Y. Sakai, T. Yamazaki, and T. Fukuta Pelvic lymph node metastasis of uterine cervical cancer Gynecol. Oncol. 27 1987 150 158
8. T. Kamura, N. Tsukamoto, N. Tsuruchi, T. Saito, T. Matsuyama, and K. Akazawa Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy Cancer 69 1992 181 186
9. H. Pickel, J. Haas, and M. Lahousen Prognostic factors in cervical cancer Eur. J. Obstet. Gynecol. Reprod. Biol. 71 1997 209 213
10. S.D. Nathanson Insights into the mechanisms of lymph node metastasis Cancer 98 2003 413 423
11. F. Tanaka, M. Abe, T. Akiyoshi, T. Nomura, K. Sugimachi, and T. Kishimoto The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the interleukin-6 gene using adenovirus vector Cancer Res. 57 1997 1335 1343
12. S. Nagata Apoptosis by death factor Cell 88 1997 355 365
13. W. Fiers Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level FEBS Lett. 285 1991 199 212
14. M. Nakashima, K. Sonoda, and T. Watanabe Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1 Nat. Med. 5 1999 938 942
15. T. Kaku, K. Sonoda, T. Kamura, T. Hirakawa, K. Sakai, and S. Amada The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix Clin. Cancer Res. 5 1999 1449 1453
16. T. Iwasaki, M. Nakashima, T. Watanabe, S. Yamamoto, Y. Inoue, and H. Yamanaka Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1 Int. J. Cancer 89 2000 488 493
17. M. Izumi, Y. Nakanishi, I. Yoshino, M. Nakashima, T. Watanabe, and N. Hara Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell carcinoma Cancer 92 2001 446 451
18. S. Oizumi, K. Yamazaki, M. Nakashima, T. Watanabe, F. Hommura, and S. Ogura RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung Oncology 62 2002 333 339
19. T. Oshiriki, Y. Hida, M. Miyamoto, H. Hashida, K. Katoh, and M. Suzuoki RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer Br. J. Cancer 85 2001 1922 1927
20. M. Suzuoki, Y. Hida, M. Miyamoto, T. Oshiriki, K. Hiraoka, and Y. Nakakubo RCAS1 expression as a prognostic factor after curative surgery for extrahepatic bile duct carcinoma Ann. Surg. Oncol. 9 2002 388 393
21. K. Hiraoka, Y. Hida, M. Miyamoto, T. Oshikiri, M. Suzuoki, and Y. Nakakubo High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker Int. J. Cancer 99 2002 418 423
22. Y. Nakakubo, Y. Hida, M. Miyamoto, H. Hashida, T. Oshiriki, and K. Kato The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus Cancer Lett. 177 2002 101 105
23. K. Sonoda, M. Nakashima, T. Kaku, T. Kamura, H. Nakano, and T. Watanabe A novel tumor-associated antigen expression in human uterine and ovarian carcinomas Cancer 77 1996 1501 1509
24. K. Razvi, K. Sonoda, Y.S. Lee, K.F. Tham, F.K. Lim, and E.L. Yong A preliminary study of the immunohistochemical detection of a novel tumour marker, 22-1-1 antigen, in gynaecological cancer specimens Ann. Acad. Med. Singapore 28 1999 392 394
25. K. Sonoda, T. Kaku, T. Kamura, M. Nakashima, T. Watanabe, and H. Nakano Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias Clin. Cancer Res. 4 1998 1517 1520
26. S. Hsu, L. Raine, and H. Fanger The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics Am. J. Clin. Pathol. 75 1981 816 821
27. Y. Gavrieli, Y. Sherman, and S.A. Ben-Sasson Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J. Cell Biol. 119 1992 493 501
28. M. Ohta, F. Tanaka, H. Yamaguchi, N. Sadanaga, H. Inoue, and M. Mori The high expression of Fractalkine results in a better prognosis for colorectal cancer patients Int. J. Oncol. 26 2005 41 47
29. E. Kebebew, P.A. Treseler, P.H. Ituarte, and O.H. Clark Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited World J. Surg. 25 2001 632 637
30. S. Vesalainen, P. Lipponen, M. Talja, and K. Syrjanen Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma Eur. J. Cancer 30 1994 1797 1803
31. M. Yoshimoto, G. Sakamoto, and Y. Ohashi Time dependency of the influence of prognostic factors on relapse in breast cancer Cancer 72 1993 2993 3001
32. P.K. Lipponen, M.J. Eskelinen, K. Jauhiainen, E. Harju, and R. Terho Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer Eur. J. Cancer 29 1992 69 75
33. H. Rabinowich, T.E. Reichert, Y. Kashii, B.R. Gastman, M.C. Bell, and T.L. Whiteside Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes J. Clin. Invest. 101 1998 2579 2588
34. T.E. Reichert, H. Rabinowich, J.T. Johnson, and T.L. Whiteside Mechanisms responsible for signaling and functional defects J. Immunother. 21 1998 295 306
35. K. Fukuda, S. Tsujitani, Y. Maeta, K. Yamaguchi, M. Ikeguchi, and N. Kaibara The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma Gastric Cancer 5 2002 220 227
36. K. Okada, M. Nakashima, K. Komuta, S. Hashimoto, S. Okudaira, and N. Baba Expression of tumor-associated membrane antigen, RCAS1, in human colorectal carcinomas and possible role in apoptosis of tumor-infiltrating lymphocytes Mod. Pathol. 16 2003 679 685
37. Y. Nakamura, K. Yamazaki, S. Oizumi, M. Nakashima, T. Watanabe, and H. Dosaka-Akita Expression of RCAS1 in human gastric carcinoma: a potential mechanism of immune escape Cancer Sci. 95 2004 260 265
38. T. Suzuki, S. Inoue, W. Kawabata, J. Akahira, T. Moriya, and F. Tsuchiya EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions Br. J. Cancer 85 2001 1731 1737
39. A.D. Santin, A. Ravaggi, S. Belone, S. Pecorelli, M. Cannon, and G.P. Parham Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix Gynecol. Oncol. 81 2001 424 432
40. A.D. Santin, S. Bellone, M. Palmieri, B. Bossini, J.J. Roman, and M.J. Cannon Induction of tumor-specific cytotoxicity infiltrating lymphocytes by HPV16 and HPV18 E7 pulsed autologous dendritic cells in patients with cancer of the uterine cervix Gynecol. Oncol. 89 2003 271 280
41. S. Miescher, T.L. Whiteside, L. Moretta, and V. von Fliedner Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors J. Immunol. 138 1987 4004 4011
42. S. Miescher, M. Stoeck, L. Qiao, C. Bannas, L. Barrelet, and V. von Fliedner Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T cell receptor expression Int. J. Cancer 42 1998 659 666
43. G. Yogeeswaran, B.S. Stein, and H. Sebastian Altered cell surface organization of gangliosides and sialylglycoproteins of mouse metastatic melanoma variant lines selected in vivo for enhanced lung implantation Cancer Res. 38 1978 1336 1344
44. A. Raz, W.L. McLellan, I.R. Hart, C.D. Bucana, L.C. Hoyer, and B.A. Sela Cell surface properties of B16 melanoma variants with differing metastatic potential Cancer Res. 40 1980 1645 1651
45. K. Leelawat, T. Watanabe, M. Nakajima, S. Tujinda, C. Suthipintawong, and V. Leardkamolkarn Upregulation of tumor associated antigen RCAS1 is implicated in high stages of colorectal cancer J. Clin. Pathol. 56 2003 764 768
46. S. Takahashi, T. Urano, F. Tsuchiya, T. Fujimura, T. Kitamura, and Y. Ouchi EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer Int. J. Cancer 106 2003 310 315
47. I. Hashimoto, J. Kodama, N. Seki, A. Hongo, M. Yoshinouchi, and H. Okuda Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer Br. J. Cancer 85 2001 93 97
48. P.O. Van Trappen, D. Steele, D.G. Lowe, S. Baithun, N. Beasley, and W. Thiele Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis J. Pathol. 201 2003 544 554